UNSPSC 51204101: Alefacept

This classification denotes an immunosuppressant with the molecular formula C2306H3594N610O694S26, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) ELK3V90G6C, more generally known as alefacept. European Medicines Agency schedules alefacept in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20562. The term ALEFACEPT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46).

UNSPSC 51204101 Alefacept is a Commodity code that encompasses pharmaceutical products and medical supplies procured by state and local health agencies, though recent solicitations under this code show minimal activity directly tied to the nominal pharmaceutical category. State and local governments purchasing under this code include county health departments, state health and human services commissions, municipal fire and rescue divisions, and cooperative purchasing alliances serving multiple jurisdictions. The scope of work reflects a mix of pharmaceutical procurement (generic drugs, over-the-counter products, and specialty medications) and medical consumables (respiratory equipment, cardiac monitoring devices, airway supplies, bandaging materials, and emergency response supplies). Issuing bodies range from single-jurisdiction health departments to multistate cooperative purchasing vehicles that aggregate demand across dozens of participating government entities.

Recent activity includes the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) requesting proposals on January 20, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026; Seminole County, Florida issuing an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa releasing an IFB on March 25, 2026 for medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a March 13, 2026 deadline, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; and the Texas Health and Human Services Commission issuing an RFI on April 3, 2026 regarding direct-to-manufacturer pharmaceutical prescription programs. Geographic activity centers on Florida, Minnesota, Oregon, and Texas, with cooperative purchasing mechanisms expanding reach across additional states.